RenaissThera
Highly Engaged Employees
Business Services · India · 1-10 Employees
View Company Info for Free
Overview
Headquarters
7th Block Jayanagar, Bengaluru, Karnatak...Website
www.renaissthera.comRevenue
<$5 MillionIndustry
About RenaissThera
RenaissThera Org Chart
Is RenaissThera your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if RenaissThera is spiking on competitors!
Earning: See what the market has to say on RenaissThera recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
RenaissThera, which may be a good buyer, showed buying intent in Masked Content Topic
Check if RenaissThera has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at RenaissThera
Funding: Get notified immidiatlly once RenaissThera has new funding data
Click to see if RenaissThera had a recent Job posting/layoffs
Product Launch: Get notified when RenaissThera launches new products
Recommended Actions
Find VP level buyers at RenaissThera
Find 2 more new buyers
RenaissThera News & Media
RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program
BENGALURU, India, June 09, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (“RenaissThera”), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery program targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR). GIPR, an incretin receptor, is a validated target for peptide-based parenteral therapies where both stimulation and inhibition has shown efficacy in treating obesity and its co-morbidities. RenaissThera is developing n
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RenaissThera
RenaissThera is a biotechnology company developing AI-powered novel small-molecule therapies for high-unmet-need diseases, including diabetes and obesity. The company combines generative AI and machine learning platforms with drug discovery expertise to identify and optimize therapeutic candidates, focusing on affordable precision medicines for und... Read More
